Price T Rowe Associates Inc Immunity Bio, Inc. Transaction History

Price T Rowe Associates Inc

$812 Billion
Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 66,101 shares of IBRX stock, worth $191,692. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,101

Previous 56,288 17.43%

Holding current value

$191,692

Previous $145,000 37.24%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$2.32 - $3.9 $22,766 - $38,270	9,813 Added 17.43%	66,101 $199,000
Q4 2024 Feb 14, 2025	SELL	$2.56 - $6.17 $48,535 - $116,977	-18,959 Reduced 25.2%	56,288 $145,000
Q3 2024 Nov 14, 2024	SELL	$3.32 - $6.7 $184,306 - $371,943	-55,514 Reduced 42.45%	75,247 $281,000
Q2 2024 Aug 14, 2024	BUY	$4.82 - $9.15 $33,171 - $62,970	6,882 Added 5.56%	130,761 $828,000
Q1 2024 May 15, 2024	BUY	$3.23 - $6.17 $14,641 - $27,968	4,533 Added 3.8%	123,879 $667,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $11,042 - $46,025	8,834 Added 7.99%	119,346 $601,000
Q3 2023 Nov 14, 2023	SELL	$1.29 - $3.1 $41,316 - $99,286	-32,028 Reduced 22.47%	110,512 $187,000
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $37,053 - $155,237	-24,218 Reduced 14.52%	142,540 $398,000
Q1 2023 May 15, 2023	BUY	$1.35 - $4.78 $22,680 - $80,304	16,800 Added 11.2%	166,758 $304,000
Q4 2022 Feb 14, 2023	SELL	$4.35 - $6.77 $34,399 - $53,537	-7,908 Reduced 5.01%	149,958 $760,000
Q3 2022 Nov 14, 2022	BUY	$3.65 - $6.43 $40,693 - $71,688	11,149 Added 7.6%	157,866 $785,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $49,322 - $113,000	-18,404 Reduced 11.15%	146,717 $546,000
Q1 2022 May 16, 2022	SELL	$5.05 - $7.53 $132,719 - $197,895	-26,281 Reduced 13.73%	165,121 $926,000
Q4 2021 Feb 14, 2022	BUY	$5.67 - $10.18 $52,731 - $94,674	9,300 Added 5.11%	191,402 $1.16 Million
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $301,748 - $468,581	-32,906 Reduced 15.3%	182,102 $1.77 Million
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $161,858 - $270,368	12,070 Added 5.95%	215,008 $3.07 Million
Q1 2021 May 17, 2021	BUY	$12.83 - $42.25 $2.6 Million - $8.57 Million	202,938 New	202,938 $4.82 Million

Others Institutions Holding IBRX

# of Institutions

239

Shares Held

79.9M

Call Options Held

1.08M

Put Options Held

2.73M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.16B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Immunity Bio, Inc. Transaction History